Nutrigenomics Market Expected to Reach $2.1 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Nutrigenomics Market," The nutrigenomics market size was valued at $435.70 million in 2022, and is estimated to reach $2.1 billion by 2032, growing at a CAGR of 17.2% from 2023 to 2032.

Nutrigenomics is the study of understanding and identifying molecular interaction between nutrients and different dietary bioactive with the genome. Thus, this approach helps in providing better dietary regimens designed for the treatment of chronic diseases. Nutrigenomics focuses on utilizing various tools and approaches such as proteomics, bioinformatics, microarrays, genomics, and single nucleotide polymorphisms (SNPs) to improve health status and diet.

Personalized diet is influencing the growth of the nutrigenomics market share across the globe. Omics approaches such as transcriptomics, proteomics, metabolomics, food omics, lipid omics, metagenomics, and others, explain how nutrients and genes interactions are evolving to reveal differences in each individual phenotypes, including individualized health or disease conditions. Research in nutrigenetics, nutrigenomics, and systems biology can interactively contribute to personalized nutrition, and need to be considered to provide reliable biomarkers of dietary response or to estimate individual requirements. Personalized nutrition should be based on the principle that nutrients may either risk or provide protection for preventing and treating various diseases, depending on the genetic predisposition of the individual gene make-up and on their ability to regulate gene expression. The implementation of personalized nutrition therefore depends on genetic background information, biological/medical conditions such as history of diseases, intolerances or allergies, and family consideration, environmental issues such as physical activity and dietary patterns, and cultural variations affecting the individual. Advances in nutrigenetics and nutrigenomics may allow the monitoring of health maintenance and disease progression. It might also facilitate R&D of novel therapeutic approaches as well as protocols for tailored dietary guidance based on algorithms. Hence, tailor-made treatments are gaining popularity which in turn is boosting the nutrigenomics market size.

Nutrigenomics testing reports are bound by regulatory norms by the FDA for the development, marketing, labeling, promotion, manufacturing, distribution, and export of diagnostic products and genetic reports. The third-party laboratories that nutrigenomics companies contract with are administered by the Centers for Medicare and Medicaid Services (CMS) as well as agencies in various states across different regions. Thus, these companies providing nutrigenomics tests are bound by various federal, state, and foreign laws, including anti-fraud and abuse, anti-kickback, and patient privacy. Furthermore, failure to comply with applicable requirements can lead to sanctions for nutrigenomics tests providers such as withdrawal of products from the market, recalls, refusal to authorize government contracts, product seizures, and others. Therefore, governments regulations and approvals act as a barrier for the nutrigenomics market growth.

Technological advances made due to emerging technologies such as Artificial Intelligence (AI) are expected to boost the demand for nutrigenomics testing. AI can be used in identifying trends and patterns related to dietary habits, analyzing data for large-scale population and thus provide better health outcomes. Such information can be utilized in order to inform public health initiatives and develop more logical and evidence-based dietary guidelines. With the help of genetic information of the patient, doctors, consultants, and clinicians can gain a deeper understanding of the complex interplay between genetics, diet, and health, leading to more nuanced and targeted recommendations. Thus, the adoption of AI in nutrigenomics holds great benefits for the precision nutrition. Clinicians and healthcare providers can develop more productive and effective dietary interventions by utilizing the power of these emerging technologies as per the individual’s unique genetic makeup and lifestyle factors. As technological advances continue towards AI, personalized nutrition services are more likely to gain momentum in the healthcare landscape. Thus, AI will help in empowering consumers to take charge of their health and make more healthy dietary choices. These factors are anticipated to have positive impact of nutrigenomics market forecast.

The nutrigenomics market share is segmented on the basis of application, product, end user, and region. By application, it is classified into obesity, diabetes, cardiovascular diseases, and cancer research. By product, it is classified into reagents & kits and services. By end user, it is classified into online platforms, hospitals & clinics, and clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and Latin America.

The nutrigenomics market forecast also analyses the regions, among which the North America is expected to grow with the highest CAGR during the forecast period.

The key players profiled in the nutrigenomics industry market report include Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.

The report offers a comprehensive analysis of the global nutrigenomics market trends by thoroughly studying different aspects of the nutrigenomics industry including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also highlights the present scenario and upcoming nutrigenomics market trends & developments that are contributing toward the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.

Impact of COVID-19 on the Global Nutrigenomics Market

• The COVID-19 pandemic led to a spike in e-healthcare and virtual consultation services through telehealth services. With the help of telehealth services, customers can get personalized diet advised by the doctor. Moreover, clinicians are convinced that virtual consultations allow clear instructions to the patient by e-prescription and text communication which makes virtual-consultation mode safer and reliable.
• Due to the pandemic, people are becoming more aware about inhibiting healthy lifestyle in order to attain healthy status for themselves and avoid prevention of chronic diseases such as obesity, cardiovascular diseases, diabetes, and others. Thus, people are adopting personalized diets which is anticipated to boost the nutrigenomics testing market growth.
• The COVID-19 pandemic has induced the growth of AI powered healthcare system through which consumers can get access to DNA based food and lifestyle recommendations to optimize health. This in turn will generate demand for precision medicine which automatically will drive the demand for nutrigenomics testing in the future.

Key Findings of the Study

• The report provides an extensive analysis of the current and emerging nutrigenomics market analysis and dynamics. 
• Based on application, the obesity sub-segment emerged as the global leader in 2022 and also is predicted to show the fastest growth in the upcoming years.
• Based on product, the reagents & kits sub-segment emerged as the global leader in 2022 and is predicted to show the fastest growth in the upcoming years.
• Based on end user, the hospitals & clinics sub-segment emerged as the global leader in 2022 and the online platforms sub-segment is predicted to show the fastest growth in the upcoming years.
• Based on region, North America registered the highest market share in 2022 and also is projected to be the fastest growing region during the forecast period